Abbott to Initiate Trial to Study MitraClip as an Option for Moderate Surgical Risk Patients
- New clinical trial will assess first-of-its-kind MitraClip ™ transcatheter mitral valve repair against current standard of care surgery in a new, expanded patient population (Source: Abbott.com)
Source: Abbott.com - January 13, 2020 Category: Pharmaceuticals Source Type: news
FDA Approves Less Invasive Surgical Approach for Abbott's Heart Pump to Help Patients Avoid Open Heart Surgery
- For people battling advanced heart failure, Abbott's HeartMate 3 heart pump can now be implanted through an incision in the chest wall versus open heart surgery (Source: Abbott.com)
Source: Abbott.com - January 7, 2020 Category: Pharmaceuticals Source Type: news
Abbott Hosts Conference Call for Fourth-Quarter Earnings
(Source: Abbott.com)
Source: Abbott.com - January 2, 2020 Category: Pharmaceuticals Source Type: news
Abbott Raises Quarterly Dividend 12.5%, Increasing Payouts for 48 Straight Years
(Source: Abbott.com)
Source: Abbott.com - December 13, 2019 Category: Pharmaceuticals Source Type: news
Abbott Announces Robert B. Ford to Succeed Miles D. White as Chief Executive Officer on March 31, 2020
- Mr. White will remain Executive Chairman of the Board (Source: Abbott.com)
Source: Abbott.com - November 13, 2019 Category: Pharmaceuticals Source Type: news
Abbott Announces Discovery of New Strain of HIV, Keeping Global Health Community a Step Ahead of the Virus
- Discovery marks the first time a new subtype of HIV-1 has been identified since 2000 (Source: Abbott.com)
Source: Abbott.com - November 6, 2019 Category: Pharmaceuticals Source Type: news
Americans Are Concerned About Road Safety as More States Legalize Recreational Cannabis, New Survey Finds
- One-third of Americans have heard someone say: "I drive better when I've smoked marijuana" (Source: Abbott.com)
Source: Abbott.com - October 22, 2019 Category: Pharmaceuticals Source Type: news
The Australian Red Cross Blood Service Selects Abbott's Alinity s Solution for Blood and Plasma Screening
Abbott and the Australian Red Cross Blood Service extend 30-year partnership of providing safe, life-saving blood supply in Australia (Source: Abbott.com)
Source: Abbott.com - October 21, 2019 Category: Pharmaceuticals Source Type: news
Abbott Reports Third-Quarter 2019 Results
- Third-quarter sales growth of 5.5 percent; organic sales growth of 7.6 percent (Source: Abbott.com)
Source: Abbott.com - October 16, 2019 Category: Pharmaceuticals Source Type: news
Canadians Indicate Growing Concern About Road Safety at One-Year Anniversary of Recreational Cannabis Legalization, New Survey Finds
-- Oct. 17, 2019, marks the one-year anniversary of legalized recreational cannabis nationwide (Source: Abbott.com)
Source: Abbott.com - October 15, 2019 Category: Pharmaceuticals Source Type: news
Abbott and Tandem Diabetes Care Exploring New Integrated Solutions to Improve Diabetes Management
- Companies aim to integrate Abbott's FreeStyle Libre glucose sensing technology with Tandem's insulin delivery products to expand choices for people with diabetes (Source: Abbott.com)
Source: Abbott.com - October 15, 2019 Category: Pharmaceuticals Source Type: news
Abbott and Omada Health Partner to Offer Integrated Digital Health and Coaching Experience for People with Type 2 Diabetes
- Collaboration combines Abbott ′s world-leading glucose sensing technology with Omada Health's best-in-class, proprietary digital coaching platform to provide personalized, on-the-go care (Source: Abbott.com)
Source: Abbott.com - October 14, 2019 Category: Pharmaceuticals Source Type: news
Abbott and Abbott Fund Launch 'Future Well Kids' Program to Help Students Shape Healthier Lives
- Abbott volunteers work with teachers to empower students to take charge of their health, adopting healthy habits that last a lifetime (Source: Abbott.com)
Source: Abbott.com - October 7, 2019 Category: Pharmaceuticals Source Type: news
Late-Breaking Data Shows Abbott's MitraClip ™ is Cost Effective, Increases Life Expectancy and Improves Quality of Life
- New late-breaking data at TCT 2019 demonstrate that Abbott's MitraClip ™ is cost-effective for heart failure patients with significant secondary mitral regurgitation compared to guideline-directed medical therapy alone (Source: Abbott.com)
Source: Abbott.com - September 29, 2019 Category: Pharmaceuticals Source Type: news
New Data Demonstrate Strong Outcomes for Abbott Device to Repair Leaky Tricuspid Heart Valves
- New data presented at TCT 2019 on Abbott's TriClip device from the TRILUMINATE Feasibility Study met both the primary safety and performance endpoints (Source: Abbott.com)
Source: Abbott.com - September 28, 2019 Category: Pharmaceuticals Source Type: news
